52 days ago • Posted by Charles-Henry Monchau

Swiss Digital Healthcare platform Zur Rose (ROSE) is up around 12% as BofA upgrades the stock to BUY with a CHF 500 price target

Source: Tradingview, FlowBank 

#Stocks
Zur Rose chart
bg_nwsletter